Johnson & Johnson reports mixed Q3 earnings
The company’s pharmaceutical segment performed well, while medtech suffered.
Maia is a Minnesota-based senior reporter and founding reporter of Healthcare Brew, where she covers the pharmacy industry, women’s health, digital health, and how venture capital is shaping healthcare. She previously worked as a fellow covering the aerospace industry at Insider, as well as a healthcare reporter for Becker's Hospital Review. She has won an award from the Society of Professional Journalists for her work.
The company’s pharmaceutical segment performed well, while medtech suffered.
The agreements tie pharmacy reimbursement to quality metrics rather than quantity.
Closures have led to a loss of more than 24,000 hospital beds in the last 15 years.
Figuring out who’s too “medically frail” for work requirements has been a major challenge.
Hinge Health’s CEO talks about founding the company and the recent Cylinder acquisition.
The year has come with a lot of challenges, from a tough economic environment to a rise in uninsured patients.
The tech giant’s VP of health told us how the company goes about designing new features.
The move may be a sign that Big Pharma companies are becoming more comfortable with the once-stigmatized field.
That could lead to downstream consequences for medical research, one expert says.
And more could shutter their obstetric units in the face of Medicaid cuts.